On October 24, 2019 the FTC filed a lawsuit against the publisher of books, newsletters, and other publications aimed at seniors that falsely promise to cure type 2 diabetes.
According to the FTC's complaint, publisher Agora Financial and its affiliates promoted books such as The Doctor's Guide to Reversing Diabetes in 28 Days (The Doctor's Guide) to older consumers and promised the protocol has a "100% success rate." The book is advertised as a "simple, doctor-guided, and scientifically proven protocol that can permanently cure type 2 diabetes in 28 days, without requiring dietary changes or exercise."
Marketing materials about the protocol claim that the "hidden cause" of type 2 diabetes is exposure to Non-Ionizing Radiation (NIR) from electronic devices such as computers and cell phones and that type 2 diabetes "can be cured with a combination of hard-to-find natural ingredients called "Himalayan Silk," "Epsom Blue," and "Chromanite." According to the FTC, however, there is no competent and reliable scientific evidence that electronic devices cause type 2 diabetes. The agency also stated that the supposed treatment actually "consists of common, widely available supplements, including mulberry, magnesium, and chromium, none of which can cure, treat, or mitigate the disease."
According to a news release about the lawsuit, The Doctor's Guide to Reversing Diabetes in 28 Days cost $249, "which the defendants claim is "a $750 discount," compared to what consumers would have to pay for in-person treatment using the same protocol."
The lawsuit also alleges the publisher made false claims about financial opportunities in its Lifetime Income Report newsletter and book, Congress' Secret $1.17 Trillion Giveaway — which tells consumers they are legally entitled to hundreds to thousands of dollars per month in "Congressional Checks" or "Republican Checks."
For other Recalls and Warnings click HERE.For information about reporting serious reactions and problems with medical products to the U.S. Food and Drug Administration through its MedWatch reporting program, please go to http://www.fda.gov/medwatch/how.htm.
Sign up for FREE Newsletter
BECOME A MEMBER
Instant Access to Reviews for OVER 1,000 Products!